Jiangfeng Bio is a R&D and manufacturer of digital pathology systems. Its main products are comprehensive digital pathology diagnostic systems, which can be used in medical institutions, educational institutions, and scientific research institutions such as biopharmaceuticals. At the same time, it also provides medical image processing systems such as CT, MRI, and ultrasound. and other products. Recently, Jiangfeng Bio completed the first round of C round financing of over 100 million yuan. This round of financing was led by Shengshan Capital, and Haoyue Capital served as the exclusive financial advisor for this round of financing.
This article is reproduced from: https://www.itjuzi.com/investevent/13337639
This site is for inclusion only, and the copyright belongs to the original author.